Navigation Links
ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
Date:10/4/2007

- Patient enrollment to begin in fourth quarter -

SEATTLE, Oct. 4 /PRNewswire-FirstCall/ -- ZymoGenetics, Inc. (Nasdaq: ZGEN) today announced that, together with its collaborator Merck Serono, it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) to conduct a pivotal clinical trial with the investigational new drug atacicept for the treatment of patients with lupus nephritis. This is one of two clinical studies intended to form part of the application for marketing authorization.

The randomized, double-blind placebo-controlled multi-center clinical trial will be conducted at sites in North America, Europe, Latin America, and Asia. Approximately 200 patients with active lupus nephritis will be enrolled in this trial, aimed at demonstrating the efficacy and safety of atacicept as compared to placebo.

"Together with Merck Serono, we concluded that an SPA provided the clearest path to ensure that this trial will support the application for atacicept marketing authorization," said Nicole Onetto, M.D., Senior Vice President and Chief Medical Officer. "We're pleased to have reached agreement with the FDA about the design of this study and plan to begin enrolling patients in the fourth quarter of 2007."

In the SPA process, the FDA evaluates the design of clinical trials intended to form the basis of an efficacy claim to support a new drug application. The SPA provides a binding agreement between the FDA and a company that the study design, trial size, endpoints and data analyses plan, are acceptable to the FDA and are adequate to support a license application for marketing in the U.S.

ZymoGenetics and Merck Serono are developing atacicept as a potential treatment for autoimmune diseases and B-cell malignancies. Merck Serono is the study sponsor, however ZymoGenetics will operationally conduct the lupus nephritis study. The companies plan to conduct a second study in pat
'/>"/>

SOURCE ZymoGenetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. UW-Madison to receive $125M for bioenergy research center
2. Madison to receive funding as part of $60M solar energy program
3. Software exec Jan Eddy to receive "Seize the Day" award
4. Medical College receives $377K to study brain disease
5. Lucigen receives $750K grant to boost biofuel yields
6. Medical College receives $1.4M cancer grant
7. Wisconsin biotech firm receives $107K NIH grant
8. InvivoSciences receives NIH grant for heart technology
9. Nations only stem cell bank will receive UC-San Francisco cell line
10. Medical College receives $11 million grant to study high blood pressure
11. Madison business receives $115,000 of new state biofuels funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... (PRWEB) June 18, 2013 A new ... materials, costs and other trends will highlight technical sessions ... California this fall. In its 33rd year, the three-day ... an exhibition of key suppliers, approximately 100 technical presentations ... SPIE, the international society for optics and photonics , ...
(Date:6/19/2013)... Express Diagnostics Int’l, Inc., manufacturer of ... it has received Class III medical device license approval ... DrugCheck® NxStep Onsite Drug Screen Cup in Canada. ... device in near-patient settings, such as physicians’ offices. , ... Canada Class III approval for 24 different drugs and ...
(Date:6/19/2013)... 19, 2013 Adding to their already ... stocked with Simport’s Dropette® and Heathrow Scientific disposable ... customer doing basic biology, chemistry and any type of ... For over 35 years, Simport has been supplying the ... products like the Simport Dropette®. Simport’s Dropette® is a ...
(Date:6/18/2013)... Clara, CA (PRWEB) June 18, 2013 ... to standard size SEMs but have limited performance and ... lower resolution. Full size SEMs would normally provide better ... more knowledge to operate and have a higher cost ... address the gap between these two types of ...
Breaking Biology Technology:‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 2Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 3
... N.J., March 22, 2011 VENENUM Biodesign, a drug ... its compound collection to identify hits against its novel ... it will be exhibiting at the 17th SBS Annual ... Convention Center in Orlando, Florida, March 27-31, 2011. VENENUM ...
... sensor that opens up new ways to detect a ... to hidden explosives. The sensor, which is ... on a completely new architecture and fabrication technique developed ... generated by the scattering of laser light from a ...
... March 21, 2011 Coinstar, Inc. (Nasdaq: ... in SoloHealth, a consumer-driven healthcare technology company that ... including its award-winning EyeSite® product and the next-generation ... "As a leader in automated retail, ...
Cached Biology Technology:VENENUM Biodesign to Exhibit at SBS 2Princeton engineers make breakthrough in ultra-sensitive sensor technology 2Princeton engineers make breakthrough in ultra-sensitive sensor technology 3Coinstar to Invest in SoloHealth 2Coinstar to Invest in SoloHealth 3
(Date:6/18/2013)... , June 19, 2013  Paris Air ... as Geotest-Marvin Test Systems) , a leading provider ... aerospace industries, is demonstrating its solutions this week ... booth 3-C82. With growing challenges including increasingly complex ... demanding efficient, feature-rich, specialized aerospace test solutions that ...
(Date:6/18/2013)... Calgary,s Faculty of Medicine have discovered a mechanism that ... Platelets, a component of blood typically associated with clotting, ... upon detection, seal it off from the rest of ... Nature Immunology this week, provide the science community ... community has known that platelets do participate in immunity, ...
(Date:6/18/2013)... the United Kingdom, the Energy Department,s National Renewable ... have recently published a paper describing a novel ... Limnoria quadripunctata , commonly known as the gribble. ... exhibit a relatively unique ability to produce their ... break down the biomass they eat. New biomass-degrading ...
Breaking Biology News(10 mins):Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3Immunity mechanism discovered 2Novel enzyme from tiny gribble could prove a boon for biofuels research 2
... restriction in an environment that promotes overeating and inactivity ... This behavior may contribute to the increased risk ... hours, according to a research abstract that will be ... Meeting of the Associated Professional Sleep Societies (APSS). ...
... YORK (June 10, 2008) The Wildlife Conservation Society ... del Fuego to help protect the guanaco a ... herds from the Andean Plateau to the steppes of Patagonia., ... million animals that live in highly fragmented populations due to ...
... developed at The University of Texas at Austin that ... response has been used to create acellular nerve grafts ... also shows early promise of the detergent solution having ... solution combined with an enzyme treatment conceived at ...
Cached Biology News:Sleep restriction results in increased consumption of energy from snacks 2Study of guanacos launched in Chile 2Engineer develops detergent to promote peripheral nerve healing 2